Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Inge Johnsen

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Oncoimmunology|January 27, 2017
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockadeNina Eissler, Yumeng Mao, David Brodin, et al.
Cancer Letters|August 2, 2011
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cellsPaula Schiapparelli, Mehdi H Shahi, Mónica Enguita-Germán, et al.
Cancers|January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma GrowthCecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer|April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastomaCecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
International Journal of Molecular Sciences|April 12, 2022
The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell CarcinomaKashif Rasheed, Ugo Moens, Benedetta Policastro, et al.
Cancers|February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in VitroConny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
International Journal of Cancer|December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivoEbba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
Cancer Letters|June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitationsMagnus Lindskog, Christian Spenger, Tomas Klason, et al.
Plos One|January 26, 2012
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastomaAgnes Rasmuson, Anna Kock, Ole Martin Fuskevåg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2020
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targetingAnna Kock, Filip Bergqvist, Julia Steinmetz, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Oncoimmunology|January 27, 2017
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockadeNina Eissler, Yumeng Mao, David Brodin, et al.
Cancer Letters|August 2, 2011
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cellsPaula Schiapparelli, Mehdi H Shahi, Mónica Enguita-Germán, et al.
Cancers|January 1, 2020
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma GrowthCecilia Dyberg, Teodora Andonova, Thale Kristin Olsen, et al.
BMC Cancer|April 3, 2016
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastomaCecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, et al.
International Journal of Molecular Sciences|April 12, 2022
The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell CarcinomaKashif Rasheed, Ugo Moens, Benedetta Policastro, et al.
Cancers|February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in VitroConny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
International Journal of Cancer|December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivoEbba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
Cancer Letters|June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitationsMagnus Lindskog, Christian Spenger, Tomas Klason, et al.
Plos One|January 26, 2012
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastomaAgnes Rasmuson, Anna Kock, Ole Martin Fuskevåg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2020
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targetingAnna Kock, Filip Bergqvist, Julia Steinmetz, et al.
Pageof 9